Oak Ridge Investments’s Axonics, Inc. Common Stock AXNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-80,529
| Closed | -$5.6M | – | 176 |
|
|
2024
Q3 | $5.6M | Sell |
80,529
-15,572
| -16% | -$1.07M | 0.49% | 47 |
|
|
2024
Q2 | $6.46M | Sell |
96,101
-2,837
| -3% | -$191K | 0.62% | 36 |
|
|
2024
Q1 | $6.82M | Buy |
98,938
+215
| +0.2% | +$14.5K | 0.69% | 36 |
|
|
2023
Q4 | $6.14M | Buy |
98,723
+47,252
| +92% | +$2.64M | 0.71% | 39 |
|
|
2023
Q3 | $2.89M | Sell |
51,471
-1,759
| -3% | -$99K | 0.37% | 78 |
|
|
2023
Q2 | $2.69M | Sell |
53,230
-1,736
| -3% | -$92.4K | 0.33% | 85 |
|
|
2023
Q1 | $3M | Sell |
54,966
-3,493
| -6% | -$204K | 0.41% | 79 |
|
|
2022
Q4 | $3.66M | Sell |
58,459
-1,263
| -2% | -$83.8K | 0.54% | 67 |
|
|
2022
Q3 | $4.21M | Sell |
59,722
-185
| -0.3% | -$12.8K | 0.64% | 49 |
|
|
2022
Q2 | $3.4M | Sell |
59,907
-13,279
| -18% | -$728K | 0.49% | 67 |
|
|
2022
Q1 | $4.58M | Sell |
73,186
-40,231
| -35% | -$2.17M | 0.51% | 61 |
|
|
2021
Q4 | $6.35M | Sell |
113,417
-2,454
| -2% | -$150K | 0.54% | 68 |
|
|
2021
Q3 | $7.54M | Sell |
115,871
-4,270
| -4% | -$291K | 0.66% | 50 |
|
|
2021
Q2 | $7.62M | Sell |
120,141
-6,720
| -5% | -$397K | 0.67% | 49 |
|
|
2021
Q1 | $7.6M | Sell |
126,861
-1,954
| -2% | -$106K | 0.71% | 48 |
|
|
2020
Q4 | $6.43M | Buy |
+128,815
| New | +$6.05M | 0.57% | 61 |
|
Other funds holding AXNX
Oak Ridge Investments's AXNX Position: Q4 2024 in Review
Oak Ridge Investments sold out of Axonics, Inc. Common Stock (AXNX) in Q4 2024, closing a stake of 80,529 shares — an estimated $5.6M sold.
Oak Ridge Investments first reported a position in AXNX in Q4 2020 and held it in 16 quarters. The position peaked at $7.62M in Q2 2021. 2 funds tracked by Wall St. Rank hold AXNX as of Q4 2024.
- Oak Ridge Investments reported no remaining Axonics, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
- Oak Ridge Investments sold 80,529 Axonics, Inc. Common Stock shares in Q4 2024, an estimated $5.6M.
- Oak Ridge Investments first reported a position in Axonics, Inc. Common Stock in Q4 2020 and held it in 16 quarters.
- Oak Ridge Investments's Axonics, Inc. Common Stock position peaked at $7.62M in Q2 2021.
- 2 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q4 2024.
Based on Oak Ridge Investments's 13F filing for Q4 2024, filed 15 Jan 2025.